Ring Therapeutics®, a life sciences company pioneering a new class of targeted medicines, today announced new data on its Vector Conjugate platform and VectorBricks™ in vitro manufacturing technology.
Cell-free protein synthesis (CFPS) eliminates the need to maintain living cells and allows greater control of reaction conditions than in vivo expression systems but is limited by its sensitivity to ...
Mission Bio, the leader in single-cell multiomics, published research in Molecular Therapy Advances showing that their ...
Peptide ligands can remove process- and product-related impurities from gene therapies better than protein ligands.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results